
Seoul, South Korea Jul 21, 2025 (Issuewire.com) - Seoul, South Korea Custics, a Korean skincare brand, has launched Lesstopy ATO Cream, a gentle and functional moisturizer formulated for sensitive and eczema-prone skin. Suitable for infants, children, and adults, the cream is designed to soothe irritation and strengthen the skin barrier.
The product features patented Lycopus Lucidus Leaf Extract, a plant-based ingredient known for its calming and skin-repairing properties. It is free from artificial fragrances, artificial colors, and steroids, offering a clean formulation for those seeking safe and effective daily skincare.
"We wanted to develop a product that parents could trust as their child's first moisturizer," said a Custics representative. "Lesstopy ATO Cream reflects our commitment to gentle yet effective care, especially for those with sensitive or eczema-prone skin."
Released earlier this week in South Korea, the product will gradually expand to global markets including Singapore, Hong Kong, Taiwan, Japan, the United States, and the UAE. It will be available through Lesstopy's official website, as well as on Shopee, Amazon, Douyin, Xiaohongshu and Qoo10 Japan, ensuring broad accessibility across major e-commerce and social commerce platforms.
The brand name "Lesstopy", a combination of "Less" and "Atopy", captures Custics' mission to minimize irritation and support healthier skin through safe, science-based formulations.




Media Contact
Glovertise
More On Newsinterestcorp ::
- Scranton Attorney Curt Parkins Joins Pisanchyn Law Firm as Firm Secures Major Car Accident Ruling
- Eagle Coins Gold and Silver Buying – Best Cash for Coins Service in Cape Cod
- Paradise Is the Sales Pitch. The Truth Is Something Else Entirely.
- Tech YouTuber Granted Geek Interviews OWC CEO Larry O’Connor on AI, Helios S5, and the Future of Upgradable Tech
- Machon Thomas, RN, Honored by America’s Best in Medicine as RN Case Manager at Baylor Scott - White Health
010-9191-6367
38, Yeongdong-daero 112-gil
Source :Custics
This article was originally published by IssueWire. Read the original article here.